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Jeremy Fleeks, Mark O. Palmier, and Steven R. Van Doren*
Department of Biochemistry, University of Missouri, Columbia, MissouriABSTRACT The greater activity of MMP-12 than MMP-3 toward substrates from protein ﬁbrils has been quantiﬁed. Why is
MMP-12 the more active protease? We looked for behaviors associated with the higher activity of MMP-12 than MMP-3, using
nuclear magnetic resonance to monitor backbone dynamics and residue-speciﬁc stabilities of their catalytic domain. The proteo-
lytic activities are likely to play important roles in inﬂammatory diseases of arteries, lungs, joints, and intestines. Nuclear magnetic
resonance line broadening indicates that regions surrounding the active sites of both proteases sample conformational substates
within milliseconds. The more extensive line broadening in MMP-3 suggests greater sampling of conformational substates,
affecting the full length of helix B and b-strand IV forming the active site, and more remote sites. This could suggest more excur-
sions to functionally incompetent substates. MMP-3 also has enhanced subnanosecond ﬂuctuations in helix A, in the b-hairpin of
strands IV and V, and before and including helix C. Hydrogen exchange protection in the EX2 regime suggests that MMP-3
possesses 2.8 kcal/mol higher folding stability than MMP-12(E219A). The b-sheet of MMP-3 appears to be stabilized still
more. The higher stability of MMP-3 relative to MMP-12 coincides with the former’s considerably lower proteolytic activity.
This relationship is consistent with the hypothesis that enzymes often trade stability for higher activity.INTRODUCTIONElucidating relationships of dynamics in enzyme function is
an important challenge. Activity of diverse enzymes has
been related not only to their intrinsic dynamics on pico-
second-to-millisecond timescales as reviewed by Boehr
et al. (1), but also to their folding stability (2,3). The stability-
function hypothesis suggests that optimization of enzymes
to enable interaction with substrates and transition states
detracts from internal packing interactions that would stabilize
the protein structure, conferring marginal stability (2,3).
Herein, we compare the activities, backbone fluctuations,
and folding stability of two metallated proteases, as part of
an effort to account for differences in their activity that would
appear tobe significant in the context of inflammatorydiseases.
The proteolytic enzyme matrix metalloproteinase-12
(MMP-12 or metalloelastase) secreted by macrophages holds
special interest due to its importance in major diseases of
arteries and lungs, regulation of inflammatory responses in
lungs, and digestion of key protein substrates, including
fibrils such as elastin that resist hydrolysis (4).
Biochemical investigations (5) (C. M. Overall, University
of British Columbia, personal communication, 2008) have
raised the question: Why is MMP-12 so active? BecauseSubmitted December 17, 2009, and accepted for publication April 1, 2010.
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0006-3495/10/07/0273/11 $2.00MMP-12 undergoes rapid autolysis (self-degradation),
neither the physiological nor the purified active form of
MMP-12 retains the C-terminal domain (4). The degradation
of elastin by MMP-12 in chronic inflammatory diseases of
the lungs and arteries is significant because the heavily
cross-linked elastin fibrils provide the elastic recoil of lungs
and arteries, and release of elastin fragments amplifies and
prolongs the inflammatory response in emphysema (6,7).
MMP-12 activity appears to exacerbate atherosclerosis (8)
and abdominal aortic aneurysms (9). Collagen V (from ubiq-
uitous collagen I fibrils) and a triple helical peptide derived
from it also resist proteolysis, except by MMP-2, -9, and
-12 (10–12). Alpha1-antitrypsin, collagen IV, and several
other components of the extracellular matrix are also readily
hydrolyzed by MMP-12 (13). MMP-12 readily truncates
a class of CXC chemokines, rendering them unable to bind
their receptors and providing macrophages a way to regulate
acute inflammation and resolve the initial phase of acute
inflammation of infected lungs (5).
MMP-3 (stromelysin 1) shares 60% sequence identity
with MMP-12 in the catalytic domain, making them closest
homologs. MMP-3 is associated with the cartilage degrada-
tion and inflammation of rheumatoid arthritis and osteoar-
thritis (14). Soon after stroke, MMP-3 opens the blood-brain
barrier by attacking tight junctions and basal lamina (15).
WhyMMP-12 is so active among MMPs is not clear in the
structural coordinates. The backbone conformation of the
catalytic domain of MMP-12 scarcely differs from that of
other MMPs (16). The active site clefts of the MMPs are
mostly conserved, with the exception of the S10 specificity
loops. MMPs 12, 3, 8, and 13 form a group with the largest
S10 specificity pockets (17). Despite the high structuraldoi: 10.1016/j.bpj.2010.04.002
274 Liang et al.similarities among MMP catalytic domain, MMP-12
possesses the only catalytic domain known to be sufficient
for high activity toward protease-resistant elastin (4),
collagen V (11), a triple helical peptide from collagen V
(12), and the ELR sequence of CXC chemokines (5). In
contrast, MMP-2 and -9 require their fibronectin-like inserts
for elastolytic (18) and collagenolytic activities (19,20).
We have investigatedwhether dynamics and stability could
be factors in the high activities of MMP-12 toward pathophy-
siologically important substrates. In inhibitor complexes of
MMPs, loops of the catalytic domain display a structural vari-
ability suggesting mobility (16,21) that is partially corrobo-
rated by nuclear magnetic resonance (NMR) relaxation of
the loops (21,22). Backbone dynamics studies of inhibitor
complexes of MMP-3 catalytic domain found the S1–S3
subsites to be rigid and the S10-S30 subsites to be rigid with
inhibitor bound to them but flexible when inhibitors instead
occupied the S1–S3 subsites (23). We have quantitatively
compared the activity, backbone rigidity, and stability (under
EX2 conditions) of the catalytic domain of MMP-12 and
MMP-3, both unfettered by inhibitor. The catalytic domain
of MMP-12 exhibits clearly higher activity, more rigidity of
its backbone, and lower folding stability than its counterpart
of theMMP-3 catalytic domain that hasmore internal motions
throughout. The greater stability of less active MMP-3 cata-
lytic domain is consistent with the hypothesis of tradeoffs
between stability and function, whereby stabilizingmutations
of enzymes diminish activity (2).MATERIALS AND METHODS
15N NMR relaxation and its interpretation
The 15N relaxation rates of TROSY-sharpened R2
a, fast relaxing R2
b, and
two-spin order R1
2HzNz were measured at 81.1 MHz using pulse sequences
and relaxation periods incremented in time steps of (pJNH)
1 (24). The
cross-correlation rate hxy was determined from R2
a and R2
b (24) and directly
using the pulse sequence of Liu and Prestegard (25) with a constant time
period of 42 ms. The exchange broadening Rex results from this combination
of the relaxation rates,
Rex ¼ Ra2  R2HzNz1 =2 hxyðk 1Þ þ RN1 =2; (1)
where k is 1.4 from the trimmed mean of 1 þ (R2a-R12HzNz/2)/hxy (24). The
baseline scatter (Fig. 1, c and d) was attributed to variability in the 15N CSA
tensors (24).
15N relaxation rates R1 and R2 were measured with pulse sequences (26)
enhanced with flip back pulses. The CPMG trains for R2 employed radio-
frequency field strength gB1 of 7200 Hz with p-pulses spaced 1.2 ms apart.
Relaxation periods for R1 ranged from 20 to 600 ms at 60.8 MHz or to
800 ms at 50.7 MHz and from 10 to 130 ms for R2 at 60.8 MHz. Fitting
uncertainties in relaxation rates were simulated by introducing random error
with SPARKY. Five pairs of {1H}15N steady-state nuclear Overhauser
effect (NOE) spectra of MMP-12 (E219A) and six pairs for MMP-3 catalytic
domain provided averages and standard deviations. Steady-state 15N{1H}
NOE spectra (26) were measured with and without 4 s of proton saturation,
in an interleaved manner to maintain identical conditions. The unsaturated
reference spectra used relaxation delays of 6 s to allow water magnetization
to recover. A TROSY-enhanced, relaxation-compensated CPMG pulse
sequence was used to identify sites of chemical exchange broadeningBiophysical Journal 99(1) 273–283(27). Its p-pulses were issued with gB1 of 5100 Hz. Delays used within
the CPMG trains were tcp ¼ 0.833 ms or 5.5 ms, i.e., 1.7 ms or 11 ms
between p pulses. Relaxation periods for the exponential decays ranged
up to 154 ms. Uniformity of recovery was improved with the DCCPSS- pre-
sequence (28).
To identify residues that were free of internal motion and with the 15N
relaxation suitable for modeling rotational correlation time tc and diffusion
tensor, coarse-filtering was performed to remove mobile residues evident
by low {1H}15NNOEor high 15NR2 (unless
15NR1 is low) (29). Fine filtering
followed, according to Ding et al. (30). Diffusion tensor parameters q, f,Dk,
and Dt were fitted to the fine-filtered set of residues, their 60.8-MHz R1 and
R2 values, using Tensor2 (31), and PDB coordinates 1bm6 for MMP-3 cata-
lytic domain and 2poj forMMP-12(E219A).Model-free simulations fitted the
relaxation measurements at 60.8 MHz (R1, R2, and
15N{1H} NOE) and 50.7
MHz (R1) to one of five spectral density functions (Table S3 in the Supporting
Material) using the program ModelFree 4.1 by Professor A. G. Palmer. The
15NCSAwas set to the approximation of170 ppm and theN-H bond length
to 1.02 A˚. Akaike’s information criterion was used for statistical selection of
spectral density functions differing in use of te and Rex (32).Hydrogen exchange protection
Hydrogen-deuterium exchange (HDX) was initiated by dissolving the
lyophilized MMP in 2H2O and centrifuging briefly to remove undissolved
protein. HDX rates in MMP-12(E219A) and MMP-3 catalytic domain
were monitored by a series of 15N HSQC spectra at 26C and 600 MHz
collected over periods of 72 and 86 h, respectively. Each exchange rate
kex is the exponential decay rate constant fitted to the decay of peak heights
with time after dissolving in 2H2O. The intrinsic rate of random coil HX, krc,
was calculated (33) using the program SPHERE (http://www.fccc.edu/
research/labs/roder/sphere/sphere.html). The Gibbs free energy of protection
from hydrogen exchange, DGHX, was calculated from kex and krc (adjusted
for the conditions of pH 6.6 and 26C) using Eq. 2 (33):
DGHX ¼ RTlnðkex=krcÞ: (2)
RESULTS
MMP-12 is more active than MMP-3
We compared proteolytic enzyme kinetics, backbone
dynamics, and stabilities of the inhibitor-free catalytic domain
of MMP-3 and MMP-12. We refer to the former as MMP-3
catalytic domain. NMR studies used MMP-12 preserved by
E219A substitution of the general base (12,34), which we
name MMP-12(E219A), inasmuch as its active form in vivo
retains only the catalytic domain (4). MMP-12 exhibits
higher, and MMP-3 catalytic domain lower, second-order
rate constants, kcat/Km, toward a short peptide substrate (FS-
6), substrates from protease-resistant elastin and collagen V
fibrils (fELN-125 and a1(V) THP), and substrates from
collagen I and IV, as listed in Table 1. The differing activities
but close structural resemblance and 60% sequence identity of
these two MMP catalytic domain makes them well suited for
comparing properties that would distinguish them.
Millisecond ﬂuctuations surround active site,
especially in MMP-3
We investigated the scope of conformational fluctuations
occurring in the backbone of each protease within
FIGURE 1 Sites of conformational
exchange within milliseconds in MMP-
12(E219A) (left panels) and MMP-3 catalytic
domain (right panels) are identified by high
R2
a Hahn spin echo relaxation rates at 81 MHz
(a and b) and high Rex exchange broadening (c
and d). Secondary structure is marked by
arrows for b-strands and cylinders for a-
helices. (e–h) Residues with red (darker
gray) backbone atoms have R2
a or Rex at least
7 s1 greater than (upper threshold) the
trimmed mean of unaffected residues. In
panels e–h, orange (lighter gray) residues
have R2
a or Rex at least 3 s
1 greater (lower
threshold lines). (e and f) Standard orientation
with active site cleft running horizontally. (g
and h) View from the side, placing the cleft
at right. Zinc ions are in gray and calcium
ions are in bronze (darker gray). Helices are
colored purple (darker gray) and b-strands
green (lighter gray) in the inhibitor free struc-
tures of MMP-12(E219A) in solution (33)
(e, PDB entry 2poj) and MMP-3 catalytic
domain in crystals (57) (f, PDB entry 1cqr).
Biophysical Journal 99(1) 273–283
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TABLE 1 Kinetics of human MMP-12 and -3 catalytic domain at 25C
Catalytic domain
General metalloprotease
substrate FS-6 Elastin fELN-125 DQ-col I DQ-col IV
Triple helical
peptide a1(V) fTHPy
kcat/Km, M
1 s1 kcat/Km, M
1 s1 kcat/Km, M
1 s1 kcat/Km, M
1 s1 kcat/Km, M
1 s1
MMP-12 133,8005 650 98805 480 34,6005 700 29,2005 200 55,4005 100z
MMP-3 20,6305 30 8305 10 14,0405 30 1105 10 <48x
MMP 12
MMP 3 6.5-fold 12-fold 2.5-fold 265-fold >1000-fold
Derived from individual progress curves at low substrate in 0.1 M Tris-HCl (pH 7.5), 0.1 M NaCl, 10 mM NaCl, and 0.1 mM ZnCl2, as described in the
literature (12,43,56). Bold indicates an advantage in catalytic turnover rate kcat according to M. O. Palmier, Y. G. Fulcher, and S. R. Van Doren (unpublished).
Note that ‘‘f’’ means ‘‘labeled with fluorescent BODIPY for FRET assay’’, and ‘‘125’’ means ‘‘full-length, with apparent molecular mass of 125 kDa by SDS-
PAGE’’.
yMimics the MMP cleavage site within residues 436–447 of the a1 chain of collagen V (43).
zFrom Bhaskaran et al. (12).
xFrom Lauer-Fields et al. (10).
276 Liang et al.milliseconds, evident as exchange broadening of 15N NMR
lines resulting from equilibria with alternate structural or
chemical environments. We used dilute monodisperse solu-
tions of 0.15 mM MMP-3 catalytic domain and 0.21 mM
MMP-12(E219A) to avoid effects of self-association, as
described in the Supporting Material. 15N NMR line broad-
ening from dynamic equilibria was maximized using both
the high magnetic field strength of 800 MHz equipment
and a Hahn spin echo with only one p-pulse (24). The
method relies upon measuring the transverse relaxation rate
R2
a from the narrow member of the 15N doublet. The inher-
ently slow TROSY relaxation of R2
a provides much dynamic
range for monitoring the exchange broadening Rex. Contri-
butions from relaxation rates called longitudinal two-spin
order R1
2HzNz, cross-correlation rate hxy, and R1
N were sub-
tracted from R2
a to estimate Rex (Eq. 1) (24). In both MMP-
12(E219A) and MMP-3 catalytic domain, elevation of 15N
R2
a and Rex is observed in seven locales: the N-terminus;
the S-shaped III–IV loop; the b-hairpin formed by strands
IV and V (sIV–sV); the V-B loop; the C-terminal end of
helix B (hB); the B-C loop residues that include the lower
lip of the active site cleft; and the N-terminal half of helix
C (hC) (Fig. 1). These comprise 37 residues of MMP-
12(E219A) and at least 63 residues of MMP-3 catalytic
domain. These regions with excess line broadening from
conformational fluctuations surround the active site cleft.
The enrichment of peaks of MMP-3 catalytic domain with
severe line broadening (Fig. 1) is striking throughout hB
and sIV that form the active site cleft, in adjacent b-strand
sV, near the C-terminal end of sIII, and at the C-terminal
end of hA that abuts hB on the back (Fig. 1, f and h). The
excess line broadening implies that the regions around the
active sites undergo fluctuations within milliseconds to
conformational substates of modestly higher free energy,
especially throughout hB and sIV of the MMP-3 active site.
The envelopment of the active site by regions with milli-
second motions is clarified in the side views of Fig. 1, g and h.
Almost half or 17 of the same residues of MMP-
12(E219A), plus seven others, also exhibit less line broad-Biophysical Journal 99(1) 273–283ening in relaxation dispersion at 61 MHz (Fig. 2 a). The
timescales of these conformational fluctuations overlap the
range between the 1.7 ms and 11 ms delay periods between
the p-pulses of the TROSY-CPMG pulse sequence
(27).These 24 residues cluster on the left side, at C-terminal
ends of sIV and hB at the active site, and in loops near the
active site in the N-terminus, III–IV, IV–V, V-B, and B-C
(S10 specificity) loops (Fig. 2 e). The distal II–III loop is
also affected. A smaller subset of 11 residues already identi-
fied in MMP-12(E219A) also exhibit line broadening from
conformational fluctuations occurring within the 1.2 ms
CPMG delay periods of conventional 15N R2 relaxation at
61 MHz (Fig. 2 c). This rate of pulsing may suppress most
line broadening present during much longer spacing used
in measuring R2
a (Fig. 1 a). The broadening remaining
with the faster pulsing suggest the exchange processes to
be faster at these positions, e.g., in sIV and adjoining loops
(Fig. 2 c), than elsewhere. The relaxation data from 800-
and 600-MHz systems together identify exchange broad-
ening in 46 residues of MMP-12(E219A).
In MMP-3 catalytic domain, elevated 15N R2 values or
relaxation dispersion at 61 MHz confirmed line broadening
in 25 residues and revealed 21 additional residues with line
broadening not quantifiable in the 81-MHz relaxation data
(Fig. 2, b and d). Nearly all in this latter group sequentially
neighbor amide groups with exchange broadening in the
81-MHz relaxation data (Fig. 2 f). The lesser exchange
broadening in the measurements at 61 MHz both missed
many cases evident at 81 MHz and detected many cases of
exchange broadening too extreme to describe from the
81-MHz relaxation data. The broadening remaining with
1.2-ms spacing of p-pulses suggests faster exchange rates
in four loops (Fig. 2 d) than elsewhere. The amide groups
with 2 s1 or more of exchange broadening in the 15N R2
values or relaxation dispersion at 61 MHz are found around
the active site at sIV (His-166 coordinating the structural
zinc), IV-V loop, V-B loop, hB, and the B-C or S10 speci-
ficity loop of MMP-3 catalytic domain. The exchange broad-
ening also maps to the N-terminus, N-terminal end of hA,
FIGURE 2 15N NMR line broadening evidences of
millisecond fluctuations of MMP-12(E219A) (left panels)
and MMP-3 catalytic domain (right panels) at 26C and
61 MHz. (a and b) Relaxation-compensated TROSY-
CPMG measurements of DR2 ¼ R2(11 ms)–R2(1.7 ms)
are plotted, where 11 and 1.67 ms are the spacings between
p-pulses of the CPMG trains. (c and d) Spin-spin relaxation
rate constant R2 was measured using an HSQC-based
sequence with 1.2 ms between p-pulses (26). (Dashed
lines) Thresholds above which the excess line broadening
is considered significant. The thresholds are drawn 2 s1
above the mean R2 after fine filtering-out of residues with
internal motions (Table S2). Secondary structure is marked
as in Fig. 1. (e and f) The structures of MMP-12(E219A)
and MMP-3 catalytic domain, respectively, are depicted
with red/lighter shading of bonds of residues with
exchange broadening at 61 MHz, reproducing that at
81 MHz (Fig. 1). Blue/darker shading indicates bonds
supplementary to 81-MHz data that did not quantify the
broadening.
MMPs Trade Activity, Rigidity, and Stability 277II–III loop, sIII, S-shaped III–IV loop, and hC of MMP-3
catalytic domain (Fig. 2, b, d, and f). The apparent exchange
broadening of at least 84 residues of MMP-3 catalytic
domain (at 81 and/or 61 MHz) suggests that they sample
conformational substates.Fast ﬂuctuations
15N R1 at 51 MHz exceeding 2.1 s
1 serves as evidence for
internal motions with apparent time constant te > 1.1 ns
(35). Both MMPs display 15N R1 values at 51 MHz that
are elevated above this threshold in their III–IV, IV–V, V-
B, and B-C loops (Fig. S2, a and b). Some elevation of the
15N R1 values at 61 MHz (Fig. S2, a and b) may also corrob-
orate motions of amide bonds in the low nanosecond regime
in these four loops.
Steady-state {1H}15N NOE values have median values of
0.76 and 0.75 for MMP-12(E219A) and MMP-3 catalytic
domain, respectively (Fig. S2, c and d). More residues of
MMP-3 catalytic domain have {1H}15N NOEs below 0.7,
suggesting that those positions are enhanced in subnanosec-ond fluctuations. The lower NOE values suggest more fast
fluctuations in hA, sIV, IV–V loop, sV, V-B loop, hB, B-
C loop, and hC of MMP-3 catalytic domain that may distin-
guish it from MMP-12(E219) (Fig. S2 d). Other segments of
higher mobility in the II–III loop, III–IV loop, and S10 spec-
ificity segment of the B-C loop of MMP-12(E219A) distin-
guish it (Fig. S2 c).Hydrodynamics
An accurate model of rotational diffusion is needed for us to
assess the contributions of internal motions to NMR relaxa-
tion in model-free calculations. Initial coarse filtering-out of
mobile residues (29) leaves 99 residues of MMP-3 catalytic
domain and 96 residues of MMP-12(E219A). Their mean
15N NMR relaxation parameters are listed in Table S2 in
the Supporting Material. Subsequent fine filtering removes
residues with other evidences motions (30), leaving 37 resi-
dues of MMP-3 catalytic domain and 43 residues of MMP-
12(E219A) that would be considered rigid enough for their
15N relaxation to represent overall rotational diffusion.Biophysical Journal 99(1) 273–283
278 Liang et al.This set of MMP-3 catalytic domain residues has mean
values of 15N R1, R2, and steady-state NOE at 26
C and
14.1 T, of 1.63 s1, 14.42 s1, and 0.77, respectively (Table
S2). The set from MMP-12(E219A) has mean values of 15N
R1, R2 and NOE at 26
C and 14.1 T of 1.74 s1, 13.03 s1,
and 0.76. The higher filtered R2/R1 ratio of MMP-3 catalytic
domain suggests it may tumble slightly more slowly, with
correlation time near 9.0 ns, relative to 8.7 ns for MMP-
12(E219A) (Table S2). These correlation times are consis-
tent with monodisperse character. Fitting of diffusion tensors
to the rigid residues using TENSOR2 (31) suggests slight
axial symmetry of rotational diffusion. The MMP-3 catalytic
domain initially appears slightly more likely to behave as
a prolate ellipsoid (Table S2). MMP-12(E219A) more
clearly tumbles as an oblate ellipsoid with an apparent Dk/
Dt of 0.88 (Table S2). Optimization of hydrodynamics
parameters by model-free simulations revised Dk/Dt
slightly to 0.89 for MMP-12(E219A) and more so to 0.70
(a prolate to oblate shift) for MMP-3 catalytic domain. These
simulations left the rotational correlation time of MMP-
12(E219A) at 8.66 ns and shifted that of MMP-3 catalytic
domain down to 8.66 ns as well. These are less than reported
for free MMP-1 catalytic domain at 9.7 ns (36) and inhibitor
complexes of MMP-3 catalytic domain at 10.6–11.8 ns (23).Model-free evidence of enhanced rigidity of some
locations in MMP-12(E219A)
Spectral density functions of the model-free formalism were
fitted to their 15N relaxation shown in Fig. 2, c and d, and
Fig. S2, a–d. The resulting generalized order parameter S2
suggests amplitudes of amide bond reorientations that are
faster than the correlation time of rotational protein diffu-
sion. S2 can range from 0 for full disorder to 1.0 for full
restriction of bond reorientation on the fast timescale. Rex
reports excess line broadening attributable to dynamic equi-
libria such as conformational exchange (38). The value te
represents an apparent but qualitative time constant of
internal bond reorientation (38). Counts of residues statisti-
cally requiring Rex or te are summarized in Table S3. Fitting
with te is required for 58 residues of MMP-12(E219A) and
54 of MMP-3 catalytic domain (Table S3 and Fig. S3). The
S2 values average 0.9455 0.045 and 0.9285 0.068 across
MMP-12(E219A) and MMP-3 catalytic domain, respec-
tively (Fig. 3, a and b). The secondary structure of each
protease is similarly rigid. S2 averages 0.95 over the helices
and 0.96 across its b-sheet of MMP-12(E219A), compared
to 0.94 over the helices and 0.92 across the b-sheet of
MMP-3 catalytic domain.
Inspection of fitted S2 and Rex suggests that MMP-
12(E219A) is more rigid than MMP-3 catalytic domain at
some locations (Fig. 3). In particular, the locale just before
and including hC is more rigid in MMP-12(E219A), with
mean DS2MMP12–MMP3 ¼ 0.08. Five of the seven residues
rigidified on the subnanosecond scale in this segment ofBiophysical Journal 99(1) 273–283MMP-12(E219A) are conserved between the two proteases:
Phe-248, Leu-250, Ser-251, Ile-255, and Gly-257 (Fig. 3 e).
MMP-12(E219A) also exhibits greater rigidity of single resi-
dues in and near the b-sheet at sI, sIII, sIV, the IV–V loop,
the V-B loop, and perhaps sV (Fig. 3, a, b, and e). Both
decreased and increased rigidity may occur at a few positions
within the III–IV and B-C loops (Fig. 3, a, b, and e).
The E219A lesion in hB in MMP-12 seems to be enhanced
in fast fluctuations relative to the wild-type Glu-203 counter-
part of MMP-3 catalytic domain, i.e., its DS2MMP12-MMP3 ¼
0.16 (Fig. 3 e). This coincides with the very small cavity
introduced by the smaller side chain (34).
The Rex term is statistically warranted for model-free
fitting of 15N exchange broadening of 78 residues of
MMP-3 catalytic domain and 54 residues of MMP-
12(E219A) (Table S3). The statistics confirm most cases of
broadening observed as elevated relaxation rates at 14.1 T.
The statistics also suggest a need for small Rex terms at
some sites lacking clearly elevated relaxation rates, such as
b-strand I of both proteases and in MMP-12 the I-A and
A-II loops and much of hA and hB (Fig. 3, c and d). The
Rex terms of MMP-3 catalytic domain average larger at 4.8
s1 than those of MMP-12(E219A) at 2.5 s1. Additional
residues of MMP-3 catalytic domain needing Rex terms
appear in b-strands sI and sIII, helices hA and hC, and the
III–IV, V-B and B-C loops (Fig. 3, c, d, and f).MMP-3 catalytic domain is more stably protected
from hydrogen exchange
We sought to compare the global and residue-specific stabil-
ities of these two MMP catalytic domain, using NMR to
measure the protection of their amide groups from hydrogen
exchange (HX). In assessing how adequately MMP-
12(E219A) may represent wild-type MMP-12 in such
studies, we found them to be similarly sensitive to chemical
denaturation within the uncertainties (Fig. S4).
HX behavior in the EX2 regime is an excellent means of
measuring protein folding stability globally (39), subglobally,
and locally (40). EX2 refers to the limit of HX where the
closing of the hydrogen bond ismuch faster than the exchange
step (kcl >> krc), making the rate-limiting step the intrinsic
rate of HX from the random coil state, krc (41). Consequently,
the Gibbs free energy of protection of amide protons fromHX
in the EX2 regime can be calculated from measured rate
constants of the exchange, kex, using Eq. 2.EX2 hydrogen exchange behavior
After plunging each lyophilized MMP into D2O, the
ensuing HDX revealed that deuterons replace several amide
protons of MMP-3 catalytic domain >10-fold more slowly
than the slowest case in MMP-12(E219A) (Fig. S5, a and
b). We investigated the HX regime by plotting measured
kex against krc (42) and clustering them into tiers of similar
FIGURE 3 Model-free parameters fitted to 15N relaxa-
tion (26C) of MMP-12(E219A) (panels at left) and
MMP-3 catalytic domain (panels at right), i.e., generalized
order parameters S2 (a and b) and line broadening term Rex
(c and d). (e) Differences in S2 of MMP-12 (E219A) from
the equivalent position in MMP-3 catalytic domain are
plotted. Secondary structure is marked as in Fig. 1. (f) Solid
representation indicates MMP-3 residues (PDB entry 1cqr)
with Rex> 4 s
1 and medium shading represents those with
Rex from 1 to 4 s
1.
MMPs Trade Activity, Rigidity, and Stability 279apparent stability to HDX (Fig. S5, a and b). The EX2
regime exhibits a theoretical slope of one and the EX1
regime a theoretical slope of zero in log-log plots of kex
versus krc (42). The slopes of the tiers are much closer to
one than zero for both MMP catalytic domain, even for
the faster exchanging residues (Fig. S5, a and b). Thus,
both MMP constructs appear to have kcl >> krc of 1000–
1400 min1 (Fig. S5, a and b), satisfying the EX2 limit
and justifying the use of Eq. 2.
Stabilities
In MMP-12(E219A), at least 55 residues were protected
from HDX. The bulk of them have an apparent DGHX,app
of 5.5–7.4 kcal/mol (Fig. 4 a). Several residues display
higher apparent DGHX,app in the range of 7.6–9.8 kcal,
particularly in hA and hB, but also in sI and near the
N-terminus of hC (Fig. 4 a). Averaging the three highest
stabilities provides an initial estimate of global stability
DGHX (39) of 9.27 kcal/mol. Correction of DGHX for
proline cis-trans isomerization was shown to agree with
traditional measurements of folding stability to within
1 kcal/mol (39). This uses the following expression andtabulated equilibrium constants for cis-trans proline isomer-
ization KPro (39):
DGU ¼ DGHX ¼ DGHX 
X
ðRTlnð1 þ KProÞÞ: (3)Crystal and solution structures of MMP-12 without inhib-
itor (PDB codes 2oxu and 2poj) show that its six prolines are
in the trans conformation. The correction of 0.51 kcal/mol
results in the estimate of folding stability of DGHX* ¼
8.76 kcal/mol for MMP-12(E219A) at 26C.
More residues of MMP-3 catalytic domain, i.e., 79
residues, were protected from HDX. The bulk of its protected
residues have DGHX,app that ranges from 6.6 to 10.1 kcal/mol
(Fig. 4 b).More stably protected amide groups are observed in
sI, hA, sIII, sIV, sV, theC-terminal end of hB, and a few loops,
withDGHX,app ranging from 10.8 to 12.7 kcal/mol. Averaging
the three highest DGHX,app values among these provides an
initial estimate of global stability (39) of 12.57 kcal/mol.
The 11 prolines of the free state structure (PDB code 1cqr)
are trans, leading to a correction for cis-trans isomerization
of 1.06 kcal/mol. Thus, the folding stability DGHX* of
MMP-3 catalytic domain appears to be 11.52 kcal/mol, which
is ~2.8 kcal/mol greater than MMP-12(E219A). All fiveBiophysical Journal 99(1) 273–283
FIGURE 4 Comparison of apparent stabilities, DGHX, of
amide HDX of (a) MMP-12(E219A) and (b) MMP-3 cata-
lytic domain. (c) Comparison of the DGHX values of
aligned residues in MMP-3 and -12. (Open triangles)
Amide groups that are well protected from HDX in
MMP-3 catalytic domain but for which DGHX,MMP12 could
not be measured. These also represent a lower limit on
DGHX,MMP3–DGHX,MMP12 that assumes an upper limit on
DGHX,MMP12 of 4.2 kcal/mol, the smallest DGHX,MMP12
observed. (d) Locations where DGHX,MMP3–DGHX,MMP12
locally exceeds the global stability difference of 2.8 kcal/
mol are shaded green/darker for residues with elevated
black squares in C and olive/lighter for the open triangles
elevated in C.
280 Liang et al.b-strands and all three helices of MMP-3 catalytic domain
have amide groups that appear to be stabilized locally more
than the 2.8 kcal/mol increase in overall folding stability rela-
tive toMMP-12(E219A) (Fig. 4, b and c). The largest of these
localized increases in stability of>5 kcal/mol map to the sites
in MMP-3 catalytic domain that lack measurable HDX
protection of the equivalent positions in MMP-12(E219A)
(open triangles in Fig. 4 c). The more stabilized locales
of MMP-3 catalytic domain appear to be biggest across the
b-sheet, but appear in the helices as well (Fig. 4, c and d).DISCUSSION
More active MMP-12 versus more stable MMP-3
The greater activity of MMP-12 compared to MMP-3 cata-
lytic domain is pronounced for substrates from protease-
resistant elastin and collagens IV and V (Table 1). Structural
descriptions of these homologs have not accounted for their
differences in activity. Several residues of MMP-12 have
recently been implicated in its specificity for fibrillar
substrates (M. O. Palmier, Y. G. Fulcher, and S. R. Van Do-
ren, unpublished). Substitutions of those MMP-12 residues
modify its Km for the elastin-derived substrate. However,
the advantage of MMP-12 over MMP-3 is instead in kcat
(M. O. Palmier, Y. G. Fulcher, and S. R. Van Doren, unpub-
lished). Biophysical properties may be important in
accounting for MMP-12 advantages in kcat. Higher rigidity
and lower stability of MMP-12(E219A) have emerged to
distinguish it from MMP-3 catalytic domain.
Structural facets of stabilities by HX
Transient openings of hydrogen bonds controlling apparent
DGHX can arise from rare global unfolding events relatedBiophysical Journal 99(1) 273–283to global folding stability, as well as subglobal opening
events and frequent, localized structural fluctuations (40).
In MMP-12(E219A), the regions displaying high DGHX ap-
proaching the global stability are confined to the helices and
sI (Fig. 4 a). In MMP-3 catalytic domain, residues with high
DGHX approaching the global stability are distributed
throughout the b-sheet region, hA, and hB (Fig. 4 b). Conse-
quently, although the global stability of MMP-3 catalytic
domain appears to be 2.8 kcal/mol greater than MMP-
12(E219A), the b-sheet of MMP-3 catalytic domain has sites
with DGHX,app measured to be 4–5 kcal/mol higher than in
MMP-12(E219A) (Fig. 4, c and d). Moreover, eight amide
groups of MMP-3 catalytic domain would seem to have
DGHX,app > 7 kcal/mol larger than their counterparts in
MMP-12(E219A) with HDX too rapid to quantify (Fig. 4,
c and d). This might be explained if the b-sheet of MMP-
12(E219A) undergoes subglobal structural fluctuations that
open its H-bonds and mask underlying smaller differences
from MMP-3 catalytic domain in rare global opening events
(with DDG ¼ 2.8 kcal/mol).
Why is MMP-3 more stable than MMP-12?
Greater entropic stabilization is likely in MMP-3 catalytic
domain. An exposed residue replaced by proline or an
exposed glycine replaced by alanine typically stabilizes
a protein by decreasing the configurational entropy of un-
folding (44,45). Proline substitutions at exposed positions
with dihedral angle f near 60, especially in b-turns and
the N-cap position of helices, have consistently been stabi-
lizing (46,47). Proline introduced to exposed turns at posi-
tion iþ1 in type I and i and iþ1 in type II, stabilized several
proteins in >90% of cases by an average of 0.7 kcal/mol
(47). MMP-3 may also be stabilized by its substitutions of
MMPs Trade Activity, Rigidity, and Stability 281proline at three such exposed sites: the N-cap of hA (Asn-
126 in MMP-12), a turn in the III–IV loop (Ala-173 in
MMP-12), and a type II0 turn of the IV–V loop (Ser-189 in
MMP-12). Glycine substitutions decrease folding stability
by stabilizing the unfolded state with greater configurational
entropy (48). Inasmuch as MMP-12 possesses seven more
glycines (Gly-106, -166, -179, -186, -192, -209, and -227)
than the MMP-3 catalytic domain, MMP-12 should have
a greater configurational entropy when unfolded and a lower
folding stability as a result. The more extensive millisecond
motions of MMP-3 catalytic domain around the active site
lend enhanced configurational entropy that might stabilize
its folded state relative to MMP-12.
Enzymes trading stability for function
Increased stability with loss of activity from point mutations
of catalytically important residues was observed in the active
sites of the enzymes staphylococcal nuclease, citrate syn-
thase, barnase, T4 lysozyme, a b-lactamase, an enolase,
and thermolysin, as reviewed by Shoichet et al. (2) and
Beadle and Shoichet (3). These authors also noted tradeoffs
of stability for affinity of mutant barstar for barnase and
mutant l Cro for DNA. Shoichet et al. (2) and Beadle and
Shoichet (3) have articulated these cases into a general
hypothesis of a balance between functional activity and
destabilization of an active site. The destabilization is neces-
sitated by the loss of stabilizing packing interactions within
a protein needed to poise the active site to bind substrate
and stabilize the transition state. Accumulating six stabi-
lizing point mutations provided much less stabilization
(3.7 kcal/mol) than summing the stabilization from each
individual mutation (49). This parallels MMP-3 catalytic
domain being 2.8 kcal/mol stabilized relative to MMP-
12(E219A) despite 40% of their sequences differing.
The point mutations of the stability-function studies above
were chosen to relieve strain at the active sites (3). Perhaps
the greater rigidity and lower stability of MMP-12 are
accompanied by greater strain at its active site, to support
greater proteolytic activity than evidenced by the more
relaxed and stable MMP-3 catalytic domain. The lesser
folding stability and higher activity of MMP-12 could
account for its rapid autolysis. Perhaps this foreshortens its
lifetime of proteolytic attack upon sites of inflammation
where it has been secreted by macrophages.Comparison of ﬂexibility
MMP-12 is the more rigid enzyme andMMP-3 the more flex-
ible, with twofold as many residues with evidence of motion
on the microsecond-to-millisecond timescale. These are
concentrated around the active site region (Figs. 1 and 2).
MMP-3 catalytic domain also has some subtly greater flexi-
bility on the picosecond-to-nanosecond scale near the begin-
ning of hC and isolated sites inb-strands I, III, IV, andV, loops
flanking sIV and sV, and hA (Fig. 3 e and Fig. S2, c and d).Comparison of MMP-3 catalytic domain, free and bound
to inhibitors, suggests slow motions to be intrinsic to it.
The extensive line broadening of MMP-3 catalytic domain
implies that its greater flexibility extends to hundreds of
microseconds to milliseconds (Fig. 1 and Fig. 2, c and d).
Line broadening was also widespread but partly quenched
in inhibitor complexes of MMP-3 catalytic domain, where
Rex terms <2.8 s
1 were needed for approximately half of
residues (23). The majority of the residues in the free state
require model-free Rex terms averaging 4.8 s
1 (Fig. 3 d).
The broadening is exaggerated to a median >9 s1 in the
analysis of Fig. 1, b and d. These results indicate that
sampling of conformational substates within milliseconds
is characteristic of the region around the active site of
MMP-3 catalytic domain (Fig. 1, f and h).
Less but significant exchange broadeningmapswere found
around the active site of MMP-12(E219A) as well (Fig. 1).
Based on greater depth of hB in its free state in solution and
1H line broadening and splitting throughout hB, a slow
conformational equilibrium affecting the depth of hB was
hypothesized (34). The 15N line broadening now evident
around the active site and hB of both MMP-12 and MMP-3
(Figs. 1 and 2, and Fig. 3, c and d) could be consistent with
the possibility of slow breathing fluctuations that might allow
small changes in depth of hB or fraying of its termini.
Parallels with MMP-1 and -13
The comparison of MMP-12 with MMP-3 may be paralleled
by how MMP-13 (collagenase 3) compares with MMP-1
(collagenase 1). MMP-13 tends to be more active than
MMP-1 (50,51). Though MMP-13 and -1 share average S2
of 0.88 overall, MMP-13 is in some respects more rigid than
MMP-1. In the key S10 specificity loop, MMP-1 has higher-
amplitude subnanosecond fluctuations (low S2) thanMMP-13
(22), greater line broadening evidence of millisecond fluctua-
tions, and splitting of peaks in hB (36). The most obvious
NMR line broadening of MMP-13 (22) coincides with that
of MMP-12 and -3 at the N-terminus, C-termini of hA and
hB, sIV, and in hC, particularly around the periphery of the
active site. Thus, sampling of conformational substates around
the active sites may be characteristic of all four MMPs.
Possible roles for conformational substates
The slow mobility encompassing the active sites of MMP-3
and -12 suggests an intrinsic plasticity that could facilitate
their recognition and the hydrolysis of diverse protein
substrates. The native-state ensemble of conformations of
MMP-12 may be better poised than MMP-3 to populate cata-
lytically competent substates. These substates should stabi-
lize the transition state to accelerate proteolytic turnover,
manifest as kcat. The apparently more extensive sampling
of conformational substates of the active sites of MMP-3
(Fig. 1) and MMP-1 (36) coincides with their lower activities
(Table 1) (50,51). Perhaps the more readily populated alter-
native conformers of the active site of MMP-3 may beBiophysical Journal 99(1) 273–283
282 Liang et al.analogous to binding-incompetent substates, which were
recently described in engineered adenylate kinase that had
line broadening (more severe than in MMP-3) and lower
affinity (53). If a greater population of alternative conformers
or the MMP-3 active site are functionally incompetent, this
might account for the lower catalytic turnover kcat (M. O.
Palmier, Y. G. Fulcher, and S. R. Van Doren, unpublished),
lower catalytic efficiency kcat/Km (Table 1), and apparently
less avid inhibition by small MMP inhibitors.
The differences in flexibility of MMP-3 and -12 are not
restricted to the active site region (Fig. 1, e–h, and Fig. 3).
Cooper and Dryden (54) argued, by using statistical thermo-
dynamics, that cooperativity and long-range communication
between separated sites can be mediated by diverse changes
in frequency and amplitude of motions induced by binding,
in the absence of conformational change. This hypothesis of
allostery, mediated by changes of entropy without conforma-
tional change, may engage proximal and distal dynamics in
regulating function not only in adenylate kinase (53),
calmodulin (55), and MMPs, but in many proteins and
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